Skip to main content
. 2020 Mar 31;2020:3867198. doi: 10.1155/2020/3867198

Figure 1.

Figure 1

Treatment schedule in a mouse model of liver fibrosis. During the preventive phase, drug treatment started simultaneously with CCL4 injections from day 0. In the therapeutic phase, drug treatment was administered on day 7 or day 14 of CCL4 injections. Mice received nintedanib 30 or 60 mg/kg/day once daily. CCL4: carbon tetrachloride; i.p.: intraperitoneal.